Verano To Launch Atlas Thrive™ – Powered by MÜV™ Product Line in Canada via Licensing Agreement
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) has announced the launch of its Atlas Thrive – Powered by MÜV products in partnership with Atlas Biotechnologies. Starting July 13, 2021, these cannabis products, including transdermal patches, gels, and tinctures, will be sold through Canada’s largest pharmacy chain, Shoppers Drug Mart. This collaboration allows Verano to access a significant market, catering to over 400,000 medical cannabis patients in Canada. The introduction of these innovative products highlights Verano's commitment to expanding its footprint in the cannabis sector.
- Launch of Atlas Thrive products through Shoppers Drug Mart, enhancing market access.
- Collaboration with Atlas Biotechnologies expands distribution in Canada.
- Products cater to over 400,000 medical cannabis patients, increasing potential sales.
- None.
- Select Atlas Thrive – Powered by MÜV™ products will sell through Shoppers Drug Mart (“Shoppers”), the largest pharmacy chain in Canada. Transdermal patches will launch in July.
- Atlas will also distribute its “Powered by MÜV” branded gels, patches, and tinctures through brick-and-mortar networks in Ontario, Alberta, British Columbia, Saskatchewan, New Brunswick, Yukon and the Northwest Territories.
- The products will be available through Ontario Cannabis Stores (“OCS”) on July 13th.
CHICAGO, July 12, 2021 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the launch of Atlas Thrive – Powered by MÜV™ branded products in collaboration with Canadian partner Atlas Biotechnologies Inc. (“Atlas”). Powered by MÜV patches, gels and tinctures will be available exclusively through Shoppers Drug Mart’s online storefront at launch. Verano and Atlas will bring Powered by MÜV products to brick-and-mortar stores across Canada with a launch date of transdermal patches at OCS on July 13.
“We’re pleased by the scope of this opportunity and the expanded footprint it provides Verano in accessing the Canadian cannabis market through the largest pharmacy chain in the country,” said George Archos, Verano Co-Founder and CEO. “The prospect of introducing our award-winning MÜV products to a new market and new patients and consumers is an exciting opportunity for the Company.”
“As Atlas expands its distribution nationally and globally, we are excited to introduce Atlas Thrive Powered by MÜV technology in partnership with Verano. As a leader in the Canadian cannabis space, we are keen to provide effective, smokeless, and reliable health and wellness solutions to millions of Canadians,” said Sheldon Croome, Atlas Founder and CEO. “We are pleased to be working closely with Verano, an industry leader in the USA, to make these new treatments available to a wider range of patients and consumers.”
The patented MÜV products, including fast-acting patches, gels, and tinctures, will be available for purchase online in July for medical cannabis patients in Canada under the Atlas Thrive™ brand through Shoppers Drug Mart. Shoppers Drug Mart is the largest pharmacy chain in Canada, which is accessible to over 400,000 patients with medical cannabis prescriptions.
The Atlas Thrive MÜV THC Tincture and 1:1 Transdermal Patch will also be launching through OCS and available to the Ontario market online, and across over 800 retailers, on July 13, with Alberta following suit in August.
About Verano
Verano Holdings Inc. is a leading, vertically-integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands: Verano™, Avexia™, Encore™, and MÜV™. The company’s portfolio encompasses 14 U.S. States, with active operations in 11, which includes nine production facilities comprising approximately 770,000 square feet of cultivation. Verano designs, builds, and operates dispensaries under retail brands Zen Leaf™ and MÜV, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.
About Atlas
Atlas Biotechnologies Inc. is based in Edmonton, Canada and its wholly owned subsidiaries, Atlas Growers Ltd. is federally licensed in Canada for cultivation and production of cannabis products, with a focus on health and wellness. Atlas currently produces flower, extract, topical and edible formulations with medical distribution across Canada and adult-use distribution in 7 provinces and territories, accessing over
Forward Looking Statements
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements include, but are not limited to statements or information with respect to the Company’s position in the marketplace and the accretive nature of licensing arrangements.
Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements, including, without limitation, the risk factors discussed in the Company's filings on SEDAR at www.sedar.com.
The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.
Contacts:
Investors:
Verano / Aaron Miles / Chief Investment Officer / aaron@verano.holdings
Atlas / Christian Lopez / Investor Relations / christianl@atlasgrowers.com
Media:
Verano / David Spreckman / VP, Marketing & Communications / david@verano.holdings / 312-819-4852
Atlas / Jeffrey R. Gossain / COO / jeffrey@atlasgrowers.com
FAQ
What products is Verano launching in July 2021?
Where will Verano's Atlas Thrive products be sold?
When will Verano's products become available in Ontario?
What is the significance of the partnership with Atlas Biotechnologies?
How many medical cannabis patients in Canada have access to these products?
